Preanalytical variables in coagulation testing [2]

Blood Coagulation and Fibrinolysis

Volumn 18, Issue 1, 2007, Pages 86-89

  Favaloro, Emmanuel J ^a,b  

^a WESTMEAD HOSPITAL   (Australia)

^b SWAHS   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; LUPUS ANTICOAGULANT;

ANALYTIC METHOD; BLOOD CLOTTING FACTOR 5 DEFICIENCY; BLOOD CLOTTING TEST; BLOOD FILTRATION; BLOOD SAMPLING; BLOOD STORAGE; BLOOD TRANSFUSION; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; HEMOPHILIA A; HEMOSTASIS; HUMAN; LETTER; PARTIAL THROMBOPLASTIN TIME; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTHROMBIN TIME;

BLOOD COAGULATION TESTS; DIAGNOSTIC ERRORS; FILTRATION; HUMANS;

EID: 33845803730     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3280116c73     Document Type: Letter

References (13)

1. Sheppard CA, Channell C, Ritchie JC, Duncan A. Pre-analytical variables in coagulation testing. Blood Coag Fibrinolysis 2006; 17:425-426.
2. Favaloro EJ, Mohammed A, Coombs R, Mehrabani PA. Filtered plasma as a potential cause of clinical misdiagnosis: inappropriate testing in a haematology laboratory. Br J Biomed Sci 1995; 52:243-248.
3. Favaloro EJ, Facey D, Grispo L. Laboratory assessment of von Willebrand factor: use of different assays can influence the diagnosis of von Willebrand's disease, depending on differing sensitivity to sample preparation and differential recognition of high molecular weight VWF forms. Am J Clin Pathol 1995; 104:264-271.
4. Favaloro EJ, Bonar R, Duncan E, Earl G, Low J, Aboud M, Just S, Sioufi J, Street A, Marsden K. (on behalf of the RCPA QAP in Haematology Haemostasis Committee). Identification of factor inhibitors by diagnostic haemostasis laboratories: a large multi-centre evaluation. Thromb Haemost 2006; 96:73-78.
5. Arkin CF, Adcock DM, Ernst DJ, Marlar RA, Parish GT, Szamosi DI, Warunek DJ. Collection, transport, and processing of blood specimens for testing plasma-based coagulation assays; approved guideline. 4th ed. Wayne, PA: National Committee for Clinical Laboratory Standards; 2003.
6. Favaloro EJ, Nair SC, Forsyth CJ. Collection and transport of samples for laboratory testing in von Willebrand's disease (VWD): time for a reappraisal? Thromb Haemost 2001; 86:1589-1590.
7. Favaloro EJ, Bonar R, Sioufi J, Hertzberg M, Street A, Lloyd J, Marsden K, (on behalf of the RCPA QAP in Haematology Haemostasis Committee). Laboratory diagnosis of von Willebrand disorder: current practice in the Southern Hemisphere. Am J Clin Pathol 2003; 119:882-893.
8. Favaloro EJ, Soltani S, McDonald J. Potential laboratory misdiagnosis of haemophilia and von Willebrand Disorder due to cold activation of blood samples for testing. Am J Clin Pathol 2004; 122:686-692.
9. Böhm M, Täschner S, Kretzschmar E, Gerlach R, Favaloro EJ, Scharrer I. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand's disease. Blood Coag Fibrinolysis 2006; 17:39-45.
10. Refaai MA, Van Cott EM, Lukoszyk M, Hughes J, Eby CS. Loss of factor VIII and von Willebrand factor activities during cold storage of whole blood is reversed by rewarming. Lab Hematol 2006; 12:99-102.
11. Favaloro EJ, Mehrabani PA. Laboratory assessment of von Willebrand factor: differential influence of prolonged ambient temperature specimen storage on assay results. Haemophilia 1996; 2:218-223.
12. Favaloro EJ, Mehrabani PA, Koutts J. Laboratory assessment of von Willebrand factor: altered interpretation of laboratory data, and altered diagnosis of von Willebrand's disease, as influenced by the use of different vWF assays and assay conditions. Clin Applied Thromb Hemost 1997; 3:110-118.
13. Favaloro EJ. Laboratory identification of von Willebrand disease: technical and scientific perspectives. Sem Thromb Hemost 2006; 32:456-471.